Changes in survival in de novo metastatic cancer in an era of new medicines. Luyendijk M, Visser O, Blommestein HM, de Hingh IHJT, et al. J Natl Cancer Inst 2023;115:628-635.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luyendijk M, Visser O, Blommestein HM, de Hingh IHJT, et al. Changes in survival in de novo metastatic cancer in an era of new medicines. J Natl Cancer Inst 2023;115:628-635.
PMID: 36978244